NEWS
Print Your Certificate
The 2025 AD Scientific Index is here—explore updated university and researcher rankings!
New! Young University / Institution Rankings 2025
New! The 2025 Edition of the AD Scientific Index is now live!
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
"Exciting Update! The 2025 Edition of the AD Scientific Index is now live!
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
login
Login
person_add
Register
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
William Dahut
National Cancer Institute - / United States
Others
AD Scientific Index ID: 4384445
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Congresses (0)
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
William Dahut's MOST POPULAR ARTICLES
1-)
Androgen deprivation therapy for prostate cancerN Sharifi, JL Gulley, WL DahutJama 294 (2), 238-244, 200511372005
2-)
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancerPW Kantoff, TJ Schuetz, BA Blumenstein, LM Glode, DL Bilhartz, ...Journal of Clinical Oncology 28 (7), 1099, 201011152010
3-)
Eligibility and response guidelines for phase II clinical trials in androgen-independent prostate cancer: recommendations from the Prostate-Specific Antigen Working GroupGJ Bubley, M Carducci, W Dahut, N Dawson, D Daliani, M Eisenberger, ...Journal of Clinical Oncology 17 (11), 3461-3467, 199911151999
4-)
Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysisX Zhu, S Wu, WL Dahut, CR ParikhAmerican Journal of Kidney Diseases 49 (2), 186-193, 20077912007
5-)
Randomized phase II trial of docetaxel plus thalidomide in androgen-independent prostate cancerWL Dahut, JL Gulley, PM Arlen, Y Liu, KM Fedenko, SM Steinberg, ...Journal of clinical oncology 22 (13), 2532-2539, 20044542004
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept